Mobile Menu

Week in Brief: Week Ending 26th September

Want to know what happened in the life sciences’ world last week? We bring you the latest news in this edition of the Week in Brief.

Chromosome shape is dynamic during cell division. The shape of chromosomes during the various stages of cell division was found to be dynamic, moving from structures with longer arms to those that were shorter and thicker. Smaller chromosomes appeared to reach a consistent shape quickly, while longer chromosomes could not achieve this before anaphase commenced.

New Huntington’s gene therapy trial reduces disease progression by 75%. Researchers at the UCL Huntington’s Disease Centre trial site have released results of their current trial testing the gene therapy AMT-130 in patients with Huntington’s disease after 36 months of treatment, which demonstrates high disease stability after a single dose.

Trisomy 21 causes age-related molecular changes. A multi-omic analysis has investigated the effect of trisomy 21, aging and sexual dimorphism on human development at a molecular level. There were changes only seen in early life stages, some relating to puberty, while others were sustained across an individual’s lifespan.

CAR-T cell modifiers for persistence in myeloma identified by CRISPR screens. To combat the issues surrounding CAR-T cell loss and myeloma relapse, in vivo CRISPR screens were performed, identifying genetic regulators of expansion and persistence. Cyclin-dependent kinase inhibitor 1B was identified as the most influential factor and ablation increased CAT-T cell function and tumour clearance.

Mapping of fibroblasts reveal these cells as universal drug targets. Spatial transcriptomics performed on fibroblasts from healthy skin and 23 skin disorders has revealed their role in the pathology in a range of conditions. Specific subtypes have been identified in healthy skin and diseased tissue across multiple organs, indicating the potential for more universal drug targets.

Introducing the Biodiversity Cell Atlas project to understand the diversity of life. This ambitious project aims to further our understanding of how genomic diversity shapes the vast number of species on our planet. In this first stage, standardised protocols for single cell sequencing will be established in preparation to construct the atlas.

Global burden of bacterial antimicrobial resistance forecasted for 2050. A systemic analysis has calculated the global burden of AMR from 1990–2021; over this time deaths in children under 5 has reduced by over 50% while it has increased in those over 70 by 80%. It is estimated that over 10 million deaths relating to AMR could occur in 2050, calling for the development of new gram-negative antimicrobials.

Glia-neuron interactions identified in Alzheimer’s Disease. A protein causal network has been developed by combining proteomics and genetic data in vulnerable disease regions of the brain. The study revealed that dysregulated protein regulatory networks between glia and neurons are associated with Alzheimer’s Disease.

3,631 new protein:protein interactions identified by deep learning model.  200 million human protein pairs were screened using 30 petabytes of data and gave rise to new interactions with a predicted precision of 90%. 3D models of these interactions have generated novel hypotheses about protein function in disease.

DNA storage in liquid crystals improves long term stability. To improve the challenge of maintaining integrity of DNA for long term information storage, researchers have designed a liquid crystal–guided DNA information preservation platform. Benefits of this platform include its thermoplasticity, alongside antimicrobial and anti-enzymatic properties.

Check out last week’s Week in Brief here.